CDKN2A and laryngeal carcinoma: Most of the observed PIK3CA mutations (8/9, 88.9%) occurred in patients without confirmed HPV infection (8/87, 9.2% in the HPV negative group) and with normal p16 expression (N = 85) in patients with laryngeal cancer.